Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386141940> ?p ?o ?g. }
- W4386141940 abstract "Abstract Background Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, life-threatening disease commonly affecting immunocompromised patients. The distribution of predisposing diseases or conditions in critically ill patients admitted to intensive care unit (ICU) and subjected to diagnostic work-up for PJP has seldom been explored. Materials and methods The primary objective of the study was to describe the characteristics of ICU patients subjected to diagnostic workup for PJP. The secondary objectives were: (i) to assess demographic and clinical variables associated with PJP; (ii) to assess the performance of Pneumocystis PCR on respiratory specimens and serum BDG for the diagnosis of PJP; (iii) to describe 30-day and 90-day mortality in the study population. Results Overall, 600 patients were included in the study, of whom 115 had presumptive/proven PJP (19.2%). Only 8.8% of ICU patients subjected to diagnostic workup for PJP had HIV infection, whereas hematological malignancy, solid tumor, inflammatory diseases, and solid organ transplants were present in 23.2%, 16.2%, 15.5%, and 10.0% of tested patients, respectively. In multivariable analysis, AIDS (odds ratio [OR] 3.31; 95% confidence interval [CI] 1.13–9.64, p = 0.029), non-Hodgkin lymphoma (OR 3.71; 95% CI 1.23–11.18, p = 0.020), vasculitis (OR 5.95; 95% CI 1.07–33.22, p = 0.042), metastatic solid tumor (OR 4.31; 95% CI 1.76–10.53, p = 0.001), and bilateral ground glass on CT scan (OR 2.19; 95% CI 1.01–4.78, p = 0.048) were associated with PJP, whereas an inverse association was observed for increasing lymphocyte cell count (OR 0.64; 95% CI 0.42–1.00, p = 0.049). For the diagnosis of PJP, higher positive predictive value (PPV) was observed when both respiratory Pneumocystis PCR and serum BDG were positive compared to individual assay positivity (72% for the combination vs. 63% for PCR and 39% for BDG). Cumulative 30-day mortality and 90-day mortality in patients with presumptive/proven PJP were 52% and 67%, respectively. Conclusion PJP in critically ill patients admitted to ICU is nowadays most encountered in non-HIV patients. Serum BDG when used in combination with respiratory Pneumocystis PCR could help improve the certainty of PJP diagnosis." @default.
- W4386141940 created "2023-08-25" @default.
- W4386141940 creator A5000117157 @default.
- W4386141940 creator A5004962453 @default.
- W4386141940 creator A5007041135 @default.
- W4386141940 creator A5009133441 @default.
- W4386141940 creator A5012922109 @default.
- W4386141940 creator A5013086263 @default.
- W4386141940 creator A5014560409 @default.
- W4386141940 creator A5014663814 @default.
- W4386141940 creator A5014684035 @default.
- W4386141940 creator A5015766857 @default.
- W4386141940 creator A5019082477 @default.
- W4386141940 creator A5019672450 @default.
- W4386141940 creator A5021259835 @default.
- W4386141940 creator A5021682088 @default.
- W4386141940 creator A5024094072 @default.
- W4386141940 creator A5024762087 @default.
- W4386141940 creator A5024835115 @default.
- W4386141940 creator A5025944964 @default.
- W4386141940 creator A5026731919 @default.
- W4386141940 creator A5027822838 @default.
- W4386141940 creator A5028388712 @default.
- W4386141940 creator A5030081518 @default.
- W4386141940 creator A5034004394 @default.
- W4386141940 creator A5034413041 @default.
- W4386141940 creator A5036721141 @default.
- W4386141940 creator A5037587167 @default.
- W4386141940 creator A5039694085 @default.
- W4386141940 creator A5040983615 @default.
- W4386141940 creator A5044118809 @default.
- W4386141940 creator A5044675287 @default.
- W4386141940 creator A5045133259 @default.
- W4386141940 creator A5046135818 @default.
- W4386141940 creator A5048017448 @default.
- W4386141940 creator A5048947719 @default.
- W4386141940 creator A5050159426 @default.
- W4386141940 creator A5051515820 @default.
- W4386141940 creator A5052329168 @default.
- W4386141940 creator A5054326254 @default.
- W4386141940 creator A5055321140 @default.
- W4386141940 creator A5055510027 @default.
- W4386141940 creator A5057058749 @default.
- W4386141940 creator A5057866828 @default.
- W4386141940 creator A5058210650 @default.
- W4386141940 creator A5058683198 @default.
- W4386141940 creator A5060644495 @default.
- W4386141940 creator A5061354333 @default.
- W4386141940 creator A5062600693 @default.
- W4386141940 creator A5063041971 @default.
- W4386141940 creator A5063972689 @default.
- W4386141940 creator A5064898626 @default.
- W4386141940 creator A5066208050 @default.
- W4386141940 creator A5067405381 @default.
- W4386141940 creator A5069139964 @default.
- W4386141940 creator A5071035881 @default.
- W4386141940 creator A5071692690 @default.
- W4386141940 creator A5071929374 @default.
- W4386141940 creator A5072442510 @default.
- W4386141940 creator A5072604522 @default.
- W4386141940 creator A5073341527 @default.
- W4386141940 creator A5074902306 @default.
- W4386141940 creator A5074930464 @default.
- W4386141940 creator A5076735376 @default.
- W4386141940 creator A5077065421 @default.
- W4386141940 creator A5077285349 @default.
- W4386141940 creator A5078680614 @default.
- W4386141940 creator A5079560138 @default.
- W4386141940 creator A5081229792 @default.
- W4386141940 creator A5081667665 @default.
- W4386141940 creator A5081784603 @default.
- W4386141940 creator A5082212076 @default.
- W4386141940 creator A5083633309 @default.
- W4386141940 creator A5083869827 @default.
- W4386141940 creator A5085960130 @default.
- W4386141940 creator A5087333640 @default.
- W4386141940 creator A5087859569 @default.
- W4386141940 creator A5088300926 @default.
- W4386141940 creator A5088883227 @default.
- W4386141940 creator A5088925956 @default.
- W4386141940 creator A5092690800 @default.
- W4386141940 creator A5092690801 @default.
- W4386141940 creator A5092690802 @default.
- W4386141940 date "2023-08-24" @default.
- W4386141940 modified "2023-10-17" @default.
- W4386141940 title "Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG" @default.
- W4386141940 cites W1803784511 @default.
- W4386141940 cites W1898928487 @default.
- W4386141940 cites W1921907741 @default.
- W4386141940 cites W1969586153 @default.
- W4386141940 cites W1983896959 @default.
- W4386141940 cites W1998140877 @default.
- W4386141940 cites W2000445173 @default.
- W4386141940 cites W2047569440 @default.
- W4386141940 cites W2078488501 @default.
- W4386141940 cites W2135138895 @default.
- W4386141940 cites W2160876613 @default.
- W4386141940 cites W2280404143 @default.
- W4386141940 cites W2290503699 @default.
- W4386141940 cites W2324816636 @default.